395 related articles for article (PubMed ID: 21458550)
61. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
[TBL] [Abstract][Full Text] [Related]
62. Betamethasone-in-cyclodextrin-in-liposome: the effect of cyclodextrins on encapsulation efficiency and release kinetics.
Piel G; Piette M; Barillaro V; Castagne D; Evrard B; Delattre L
Int J Pharm; 2006 Apr; 312(1-2):75-82. PubMed ID: 16455215
[TBL] [Abstract][Full Text] [Related]
63. Transcutaneous drug delivery by liposomes using fractional laser technology.
Fujimoto T; Wang J; Baba K; Oki Y; Hiruta Y; Ito M; Ito S; Kanazawa H
Lasers Surg Med; 2017 Jul; 49(5):525-532. PubMed ID: 27990655
[TBL] [Abstract][Full Text] [Related]
64. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
Lombardi Borgia S; Regehly M; Sivaramakrishnan R; Mehnert W; Korting HC; Danker K; Röder B; Kramer KD; Schäfer-Korting M
J Control Release; 2005 Dec; 110(1):151-63. PubMed ID: 16297487
[TBL] [Abstract][Full Text] [Related]
65. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
[TBL] [Abstract][Full Text] [Related]
66. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
67. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
68. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib.
Bragagni M; Mennini N; Maestrelli F; Cirri M; Mura P
Drug Deliv; 2012; 19(7):354-61. PubMed ID: 23043648
[TBL] [Abstract][Full Text] [Related]
69. Transfersomes--a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation.
Jain S; Jain P; Umamaheshwari RB; Jain NK
Drug Dev Ind Pharm; 2003 Oct; 29(9):1013-26. PubMed ID: 14606665
[TBL] [Abstract][Full Text] [Related]
70. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
[TBL] [Abstract][Full Text] [Related]
71. Penetration enhancer-containing vesicles: composition dependence of structural features and skin penetration ability.
Manconi M; Caddeo C; Sinico C; Valenti D; Mostallino MC; Lampis S; Monduzzi M; Fadda AM
Eur J Pharm Biopharm; 2012 Oct; 82(2):352-9. PubMed ID: 22922162
[TBL] [Abstract][Full Text] [Related]
72. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
Silva CO; Rijo P; Molpeceres J; Figueiredo IV; Ascensão L; Fernandes AS; Roberto A; Reis CP
Int J Pharm; 2015 Sep; 493(1-2):271-84. PubMed ID: 26222745
[TBL] [Abstract][Full Text] [Related]
73. Skin penetration and distribution of polymeric nanoparticles.
Alvarez-Román R; Naik A; Kalia YN; Guy RH; Fessi H
J Control Release; 2004 Sep; 99(1):53-62. PubMed ID: 15342180
[TBL] [Abstract][Full Text] [Related]
74. Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen.
Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
Pharmazie; 2007 Feb; 62(2):133-7. PubMed ID: 17341034
[TBL] [Abstract][Full Text] [Related]
75. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
76. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
[TBL] [Abstract][Full Text] [Related]
77. Visualization of ultradeformable liposomes penetration pathways and their skin interaction by confocal laser scanning microscopy.
Subongkot T; Wonglertnirant N; Songprakhon P; Rojanarata T; Opanasopit P; Ngawhirunpat T
Int J Pharm; 2013 Jan; 441(1-2):151-61. PubMed ID: 23247017
[TBL] [Abstract][Full Text] [Related]
78. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
79. Particle size of liposomes influences dermal delivery of substances into skin.
Verma DD; Verma S; Blume G; Fahr A
Int J Pharm; 2003 Jun; 258(1-2):141-51. PubMed ID: 12753761
[TBL] [Abstract][Full Text] [Related]
80. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
